Despite these limitations, this study demonstrates in a prospective cohort of COVID-19 patients at one of the largest health institutes in Mexico that measurement of galectin-3 levels upon hospital admission could be helpful in predicting disease progression. This evidence concerns the gene LGALS3 and COVID-19.